← Leaderboards
Todd Jason Green
University Of Alabama At Birmingham
$4,258,379
Attributed
$5,547,754
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $868.6K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,547,754 · 4
By mechanism
R01$4,416,250 · 2
U19$787,229 · 1
R56$344,275 · 1
Top collaborators
- Jan Novak5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Jan Novak$14,197,925
- Ming Luo$16,469,559
- Matthew B Renfrow$7,936,462
- John H Eldridge$16,167,741
- Colin Robert Reily$2,556,945
Others in their field
Top investigators on “Resolution”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$229,516,323
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ResolutionStructureComplexX-Ray CrystallographyComplementSiteGenesDockingPhenotypeDrug DesignAmino Acid SequenceBaseAntigensCloningReagentAffinityProteinsRecombinantsMultidisciplinaryLibrariesEpitopesCryoelectron MicroscopyBindingGenerations
Grant awards (13)
Core C: Immuno-Reagent Production, Validation, and Biophysical Analysis Core$434,363
U19 · FY2025 · AI · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2024 · AI · contact PI
Core C: Immuno-Reagent Production, Validation, and Biophysical Analysis Core$352,866
U19 · FY2024 · AI · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2023 · AI · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2022 · AI · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2021 · AI · contact PI
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease$515,750
R01 · FY2020 · AI · contact PI
Transcription and replication in nonsegmented negative-strand RNA viruses$367,500
R01 · FY2019 · AI · contact PI
Transcription and replication in nonsegmented negative-strand RNA viruses$367,500
R01 · FY2018 · AI · contact PI
Transcription and replication in nonsegmented negative-strand RNA viruses$367,500
R01 · FY2017 · AI · contact PI
Transcription and replication in nonsegmented negative-strand RNA viruses$367,500
R01 · FY2016 · AI · contact PI
Transcription and replication in nonsegmented negative-strand RNA viruses$367,500
R01 · FY2015 · AI · contact PI
Structural basis of vesucular stomatitis virus transcription and replication$344,275
R56 · FY2013 · AI · contact PI